Clinical Trial Update: A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports on MORAb-009 in pancreatic cancer and mesothelioma, with related ovarian cancer and non-small cell lung cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• MORAb-009 (farletuzumab)

Snippet

Sponsor: Morphotek | Conditions: Pancreatic Cancer, Mesothelioma | Phase 1 | Status: COMPLETED